At the time of writing, Vor Biopharma Inc [VOR] stock is trading at $0.17, down -0.06%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VOR shares have gain 6.81% over the last week, with a monthly amount drifted -75.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on July 26, 2022, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. Previously, Goldman started tracking the stock with Neutral rating on April 27, 2022, and set its price target to $6. On December 17, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $38 on December 03, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 02, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2021, and assigned it a price target of $40. In a note dated March 25, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $60 on this stock.
For the past year, the stock price of Vor Biopharma Inc fluctuated between $0.13 and $1.87. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $0.17 at the most recent close of the market. An investor can expect a potential return of 3429.41% based on the average VOR price forecast.
Analyzing the VOR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.08, Equity is -1.42 and Total Capital is -1.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1631 points at the first support level, and at 0.1552 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1775, and for the 2nd resistance point, it is at 0.1840.
Ratios To Look Out For
It is important to note that Vor Biopharma Inc [NASDAQ:VOR] has a current ratio of 3.88. Also, the Quick Ratio is 3.88, while the Cash Ratio stands at 2.99.
Transactions by insiders
Recent insider trading involved Attar Eyal C., CHIEF MEDICAL OFFICER, that happened on Feb 13 ’25 when 2227.0 shares were sold. Officer, EYAL ATTAR completed a deal on Feb 13 ’25 to buy 2227.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Attar Eyal C. sold 2554.0 shares on Feb 10 ’25.
